Evaluation of clinical practice regarding SGLT2 inhibitor use in patients with type 2 diabetes mellitus and established coronary artery disease in James Cook University Hospital

Clin Med (Lond). 2022 Jul;22(Suppl 4):88-89. doi: 10.7861/clinmed.22-4-s88.
No abstract available

MeSH terms

  • Cardiovascular Diseases*
  • Coronary Artery Disease* / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Hospitals
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors